Award for OVG's learning games

Developing a global framework to assess a country's readiness and resilience to introduce a new vaccine or improve uptake of an underutilized vaccine.

Monk V. et al, (2026), Expert Rev Vaccines, 25

Parental motivations, facilitators, and barriers to participating in a pediatric vaccine trial in Kathmandu, Nepal: A qualitative study.

Firth C. et al, (2026), Hum Vaccin Immunother, 22

COVID-19 vaccine effectiveness and SARS-CoV-2 variants in Nepal: Test-negative case-control study and genetic sequencing (COVVAR Nepal)

Pokhrel B. et al, (2026), Vaccine: X, 31, 100864 - 100864

Structural and immunogenic characterisation of ChAdOx1 Chik-derived Chikungunya VLPs supports a mechanistic rationale for vaccine-induced protection.

Kim YC. et al, (2026), Npj Viruses

Studying Early Life Live-Attenuated influenza virus immune Responses (STELLAR): study protocol for an exploratory observational study of the nasal mucosal and systemic immune response in healthy children given an intranasal live-attenuated influenza vaccine.

Kelleher K. et al, (2026), BMJ Open, 16

Automated virtual reality therapy to treat needle fears (trypanophobia) in adolescents in England: a proof-of-concept cohort study and a Phase II randomised controlled trial

FREEMAN D., (2026), EClinicalMedicine

Serological thresholds of risk reduction for infant group B streptococcus disease

Cantrell L. et al, (2026)

In silico post-hoc analysis of a clinically tested recombinant West Nile virus envelope protein vaccine.

Reiné J. et al, (2026), Comput Biol Chem, 122

Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults-A Pilot Study.

Alsaleh G. et al, (2026), Aging Cell, 25

Association of Diabetes Mellitus With a Shared Hyperinflammatory Immune Response in Patients With Melioidosis and Patients With Tuberculosis: An Observational Case-Control Study.

Rongkard P. et al, (2026), Open Forum Infect Dis, 13

Levels of bone formation marker P1NP in individuals over 50 years: a systematic review and meta-analysis.

Hesari E. et al, (2026), J Diabetes Metab Disord, 25

Host-microbial interactions at the nasal mucosa in young children and adults: A retrospective, cross-sectional study.

Reiné J. et al, (2026), Cell Rep, 45

Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections: a secondary analysis of observational data.

Hagedoorn NN. et al, (2026), Vaccine, 85

Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial.

Hysa A. et al, (2026), PLoS Med, 23

National Cross-Sectional Study Assessing the Positivity Rate and Clinical Manifestations of Human Bocavirus Respiratory Infections Among Hospitalized Children Under 5 Years of Age in Jordan.

Abu Lubad M. et al, (2026), Pathogens, 15

The human immune response to viral vectored vaccine regimens against Ebola virus and Sudan virus in clinical trials

Makinson R., (2026)

The impact of the COVID-19 pandemic on healthy volunteer motivations: a mixed-methods study of participants in plague vaccine trials in the UK and Uganda.

Stuart AS. et al, (2026), BMC Public Health

Willingness to accept paediatric blood sample collection for clinical research purposes in Nepal: a qualitative study.

Dahal A. et al, (2026), BMJ Glob Health, 11

Predicting trajectories of illness using RNA velocity of whole blood.

Dunican C. et al, (2026), Nat Commun, 17

Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trial.

Thorn N. et al, (2026), Lancet Infect Dis

Search results

Showing results for